Sugammadex after magnesium sulphate administration in a morbidly obese patient undergoing general anaesthesia before tracheal intubation in 90 s. NMB was maintained with subsequent boluses of rocuronium, titrated to achieve moderate NMB (T 1 -T 2 ) (rocuronium 80 mg total dose) ( Fig. 1A ). Remifentanil was stopped at the end of the uneventful 90 min surgical procedure. Ondansetron 4 mg and ketoprofen 100 mg were given i.v. to reduce postoperative nausea and vomiting (PONV) and limit the use of narcotics for postoperative pain management. A second dose of magnesium sulphate 40 mg kg
21
(LBW) was given. NMB was potentiated decreasing from T 2 to 7 post-tetanic counts. Sugammadex 4 mg kg 21 (total body weight) was administered after 6 min to reverse the rocuronium-induced NMB. Complete reversal of NMB (TOF ratio of 1.10) was achieved within 60 s. The twitch height reached a stable value of 74% within 7 min after sugammadex administration (Fig. 1B) . Desflurane was then discontinued, the patient awakened, and the tracheal tube was smoothly removed. The patient had no evidence of pain, PONV, signs of residual Correspondence NMB, or recurrent upper airway obstruction in the postoperative period.
The stress response during airway management is potentially dangerous in obese patients with increased cardiovascular risk. 3 The mean arterial pressure and plasma norepinephrine levels increase significantly after tracheal intubation and extubation in obese patients. 3 Magnesium has been used to attenuate the cardiovascular response during airway management. 4 This effect is probably secondary to a reduction in the release of catecholamines from the adrenal medulla and adrenergic nerve terminals after sympathetic stimulation. 4 Sympatholysis, vasodilatation, improved contractility, limitation of infarct size, reduced frequency of arrhythmias, and coagulation modification are all effects that may be involved in the potential cardioprotection of magnesium. 4 Sympatholysis and antagonism of N-methyl-D-aspartate receptors in the central nervous system may be also responsible for the intraoperative analgesic effect of magnesium. 5 The administration of magnesium sulphate also results in potentiation of the effects of neuromuscular blocking agents, mainly through inhibition of acetylcholine release at motor nerve terminals. 4 -7 The change in the balance between acetylcholine and rocuronium in the synaptic cleft results in the deepening of NMB. in twitch height to 65% of baseline value), much higher concentrations of sugammadex were required to reverse the block in the experimental setting. 1 Moreover, increasing the dose of sugammadex may also reduce the risk of recurrence of NMB if magnesium sulphate is given after operation. 1 6 It was found that magnesium caused only a small decrease in twitch height (to 72% of baseline twitch height) in the presence of sugammadex concentrations ranging from 5.6 to 19 mmol litre
, which represents the effect of magnesium alone.
1
In conclusion, sugammadex should be administered according to the level of NMB observed at accelerographic monitoring in the setting of magnesium sulphate administration in order to have a quick, safe, and effective reversal of rocuronium-induced NMB in morbidly obese patients. Prolonged diaphragm dysfunction after interscalene brachial plexus block and shoulder surgery: a prospective observational pilot study Editor-Interscalene blocks (ISB) result in a decrease in forced vital capacity (FVC) of 20-25%, secondary to ipsilateral hemidiaphragmatic paralysis (DP) which is known to occur in up to 100% of patients.
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1 This is known to resolve upon resolution of the anaesthetic block. However, several cases of prolonged diaphragmatic dysfunction (PDD) have been reported post-ISB, some asymptomatic. 2 -5 Consequently, we sought to study the incidence of PDD after ISB by performing pulmonary function testing on patients before and after operation. The aim was to observe the incidence of prolonged phrenic nerve dysfunction manifested by a decrease in FVC of more than 20% from the preoperative value. After IRB approval, 98 patients undergoing ISB for shoulder arthroscopy were enrolled (31 paraesthesia technique, 57 nerve stimulator, and 10 via ultrasound). FVC and negative inspiratory force were recorded and measured in the sitting position before surgery, in the recovery room, and at post-surgical follow-up (7 -14 days). Each measurement was repeated for confirmation.
Two patients had PDD at the time of post-surgical follow up as per our definition (a decrease in FVC by 20%). One was asymptomatic (paraesthesia technique) and refused further work-up. The other (nerve stimulator technique) had shortness of breath with persistent symptoms at 5 weeks after operation with elevated hemidiaphragm ipsilateral to the surgical site on chest radiograph. Diaphragmatic stimulation was noted during needle insertion. Of the 57 patients with nerve stimulator technique, 17% had diaphragmatic stimulation as well, but without sequelae. This may be indicative of the proximity of the phrenic nerve to the path travelled by the needle.
The incidence of definite PDD post-ISB and shoulder surgery in this prospective observational study was 1% (95% confidence interval 0.05 -5.03). The exact mechanism is unclear, and may be attributed to different causes. The incidence
